In this issue:
- Empagliflozin in MASLD without diabetes mellitus
- Non-invasive tests for MetALD
- Survodutide in cirrhosis
- Carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers
- Hyperferritinaemia, type 2 diabetes and MASLD
- G-CSF for severe alcohol associated hepatitis
- Hepatitis B/D infection in cirrhosis and risk of HCC
- Point-of-care testing for HCV
- Cost-effectiveness of ED based HCV screening and linkage-to-care
- TORCH-B: tenofovir disoproxil fumarate for chronic HBV with mildly elevated ALT
Please login below to download this issue (PDF)